{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:08:17Z","timestamp":1791248897971,"version":"4.1.0"},"reference-count":51,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["No.Z201100005520022,23, 25-27"],"award-info":[{"award-number":["No.Z201100005520022,23, 25-27"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["022-PUMCH-B-013, C-002, D-009"],"award-info":[{"award-number":["022-PUMCH-B-013, C-002, D-009"]}]},{"name":"Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2021YFC2501300"],"award-info":[{"award-number":["2021YFC2501300"]}]},{"name":"Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2022YFC3601800"],"award-info":[{"award-number":["2022YFC3601800"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-1-004"],"award-info":[{"award-number":["2022-I2M-1-004"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Until now, there has still been a lack of sufficient evidence on patient-reported outcomes (PROs) measured by the EuroQol-5 Dimension (EQ-5D) in patients with systemic lupus erythematosus (SLE) in China. This study aims to comprehensively assess EQ-5D outcomes and influencing factors in Chinese patients with SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A multicentre, cross-sectional study based on the Chinese Systemic Lupus Erythematosus Treatment and Research Group registry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>101 hospitals across 27 provinces of China.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>1336 patients with SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcome measures<\/jats:title>\n                  <jats:p>The information on EQ-5D was collected via an online questionnaire. Medical records were obtained from the Chinese Rheumatology Data Centre (CRDC). Clinical influencing factors related to the reported health problems were identified using multivariate logistic regression. Then, each health state was converted into a health utility score based on the Chinese 2014 tariff. Given the ceiling effects, Tobit regression models were used to analyse the factors influencing health utility scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 1336 patients with SLE were included. Of them, 626 patients (46.9%) reported health problems using EQ-5D. The proportions of patients reporting problems in mobility, self-care, usual activities, pain\/discomfort and anxiety\/depression were 12.80%, 5.24%, 14.90%, 27.47% and 30.46%, respectively. The mean utility score was 0.89 (SD: 0.15), and the mean Visual Analogue Scale (VAS<jats:underline>)<\/jats:underline> score was 76.80 (SD: 16.54). There was a statistically significant correlation (r=0.503, p&lt;0.001) between utility scores and VAS scores. Disease activity, organ damage, poor socioeconomic status, mucocutaneous involvement and high-dose glucocorticoids were associated with health utility scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>EQ-5D may be a useful, preference-based PRO measure for SLE and could potentially be integrated into routine clinical monitoring of patients with SLE and applied in economic evaluations in the future.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-096989","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:20:22Z","timestamp":1759130422000},"page":"e096989","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-reported outcome measured by EQ-5D and influencing factors among patients of systemic lupus erythematosus in China: a multicentre cross-sectional study from CSTAR Registry"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4268-9168","authenticated-orcid":false,"given":"Lu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-2511","authenticated-orcid":false,"given":"Wei","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8531-1675","authenticated-orcid":false,"given":"Bing","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Yuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-2318","authenticated-orcid":false,"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China"},{"name":"Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"2025092900201204000_15.9.e096989.1","first-page":"1640","article-title":"Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study","volume":"19","author":"McElhone","year":"2010","journal-title":"Lupus (Los Angel)"},{"key":"2025092900201204000_15.9.e096989.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0903.2004.00578.x"},{"key":"2025092900201204000_15.9.e096989.3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/annrheumdis-2023-eular.341","article-title":"OP0260\u2005global trend of the survival of patients with systemic lupus erythematosus between the 1950s to 2020","volume":"82","author":"Lim","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025092900201204000_15.9.e096989.4","doi-asserted-by":"publisher","DOI":"10.1080\/17402520600877760"},{"key":"2025092900201204000_15.9.e096989.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.117200"},{"key":"2025092900201204000_15.9.e096989.6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0266462318000326","article-title":"Health technology assessment for decision making in latin America: good practice principles","volume":"34","author":"Pichon-Riviere","year":"2018","journal-title":"Int J Technol Assess Health Care"},{"key":"2025092900201204000_15.9.e096989.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.24236"},{"key":"2025092900201204000_15.9.e096989.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540160061034"},{"key":"2025092900201204000_15.9.e096989.9","doi-asserted-by":"crossref","unstructured":"Dua AB , Touma Z , Toloza S , et al . Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep 2013;15. doi:10.1007\/s11926-013-0380-9","DOI":"10.1007\/s11926-013-0380-9"},{"key":"2025092900201204000_15.9.e096989.10","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(96)00822-6"},{"key":"2025092900201204000_15.9.e096989.11","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"2025092900201204000_15.9.e096989.12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40273-015-0295-6","article-title":"Can the EQ-5D detect meaningful change? A systematic review","volume":"33","author":"Payakachat","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"2025092900201204000_15.9.e096989.13","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1093\/rheumatology\/keab080","article-title":"EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus","volume":"60","author":"Lindblom","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025092900201204000_15.9.e096989.14","first-page":"633","article-title":"A review of health related quality of life in systemic lupus erythematosus","volume":"15","author":"McElhone","year":"2006","journal-title":"Lupus (Los Angel)"},{"key":"2025092900201204000_15.9.e096989.15","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802415527"},{"key":"2025092900201204000_15.9.e096989.16","first-page":"525","article-title":"The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus","volume":"28","author":"Wang","year":"2001","journal-title":"J Rheumatol"},{"key":"2025092900201204000_15.9.e096989.17","doi-asserted-by":"publisher","DOI":"10.2478\/rir-2021-0001"},{"key":"2025092900201204000_15.9.e096989.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"2025092900201204000_15.9.e096989.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025092900201204000_15.9.e096989.20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819"},{"key":"2025092900201204000_15.9.e096989.21","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025092900201204000_15.9.e096989.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.20412"},{"key":"2025092900201204000_15.9.e096989.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.05.007"},{"key":"2025092900201204000_15.9.e096989.24","doi-asserted-by":"crossref","unstructured":"van Vollenhoven RF , Bertsias G , Doria A , et al . 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 2021;8. doi:10.1136\/lupus-2021-000538","DOI":"10.1136\/annrheumdis-2021-eular.1192"},{"key":"2025092900201204000_15.9.e096989.25","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30037-2"},{"key":"2025092900201204000_15.9.e096989.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh624"},{"key":"2025092900201204000_15.9.e096989.27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-021-02481-3","article-title":"Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study","volume":"23","author":"Peng","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025092900201204000_15.9.e096989.28","doi-asserted-by":"crossref","unstructured":"Weinstein A , Alexander RV , Zack DJ . A review of complement activation in SLE. Curr Rheumatol Rep 2021;23. doi:10.1007\/s11926-021-00984-1","DOI":"10.1007\/s11926-021-00984-1"},{"key":"2025092900201204000_15.9.e096989.29","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008938326604"},{"key":"2025092900201204000_15.9.e096989.30","doi-asserted-by":"publisher","DOI":"10.2307\/1907382"},{"key":"2025092900201204000_15.9.e096989.31","first-page":"5","article-title":"Comparison analysis on health related quality of life among urban and rural residents in 4cities of China","volume":"34","author":"Guan","year":"2015","journal-title":"Chinese Health Econ"},{"key":"2025092900201204000_15.9.e096989.32","doi-asserted-by":"crossref","unstructured":"Wang SI , Hsieh E , L-a Z , et al . Comparative assessment of different health utility measures in systemic lupus erythematosus. Sci Rep 2015;5. doi:10.1038\/srep13297","DOI":"10.1038\/srep13297"},{"key":"2025092900201204000_15.9.e096989.33","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081022"},{"key":"2025092900201204000_15.9.e096989.34","first-page":"793","article-title":"Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports","volume":"22","author":"Bexelius","year":"2013","journal-title":"Lupus (Los Angel)"},{"key":"2025092900201204000_15.9.e096989.35","doi-asserted-by":"crossref","unstructured":"Park EH , Strand V , Oh YJ , et al . Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019;21. doi:10.1186\/s13075-019-1842-x","DOI":"10.1186\/s13075-019-1842-x"},{"key":"2025092900201204000_15.9.e096989.36","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10067-019-04485-6","article-title":"Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports","volume":"38","author":"Rom\u00e1n Ivorra","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025092900201204000_15.9.e096989.37","doi-asserted-by":"crossref","unstructured":"Tang W , Inzerillo S , Weiner J , et al . The impact of telemedicine on rheumatology care. Front Med (Lausanne) 2022;9. doi:10.3389\/fmed.2022.876835","DOI":"10.3389\/fmed.2022.876835"},{"key":"2025092900201204000_15.9.e096989.38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.47102\/annals-acadmedsg.V36N2p115","article-title":"Health-related quality of life in patients with systemic lupus erythematosus: an update","volume":"36","author":"Thumboo","year":"2007","journal-title":"Ann Acad Med Singap"},{"key":"2025092900201204000_15.9.e096989.39","doi-asserted-by":"crossref","unstructured":"Zhou T , Guan H , Wang L , et al . Health-related quality of life in patients with different diseases measured with the EQ-5D-5L: a systematic review. Front Public Health 2021;9. doi:10.3389\/fpubh.2021.675523","DOI":"10.3389\/fpubh.2021.675523"},{"key":"2025092900201204000_15.9.e096989.40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa420"},{"key":"2025092900201204000_15.9.e096989.41","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40744-023-00601-w","article-title":"Targeting DORIS remission and LLDAS in SLE: a review","volume":"10","author":"Parra S\u00e1nchez","year":"2023","journal-title":"Rheumatol Ther"},{"key":"2025092900201204000_15.9.e096989.42","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.21037\/apm-21-1485","article-title":"A systematic review and meta-analysis: effects of glucocorticoids on rheumatoid arthritis and systemic lupus erythematosus","volume":"10","author":"Sun","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2025092900201204000_15.9.e096989.43","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.106"},{"key":"2025092900201204000_15.9.e096989.44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac185"},{"key":"2025092900201204000_15.9.e096989.45","doi-asserted-by":"publisher","DOI":"10.1002\/art.24165"},{"key":"2025092900201204000_15.9.e096989.46","doi-asserted-by":"crossref","unstructured":"Zhang L , Luan W , Geng S , et al . Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China. BMC Health Serv Res 2019;19. doi:10.1186\/s12913-019-4206-y","DOI":"10.1186\/s12913-019-4206-y"},{"key":"2025092900201204000_15.9.e096989.47","first-page":"58","article-title":"Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity","volume":"20","author":"Jarpa","year":"2011","journal-title":"Lupus (Los Angel)"},{"key":"2025092900201204000_15.9.e096989.48","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker410"},{"key":"2025092900201204000_15.9.e096989.49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1573397117666210301144651","article-title":"Medication adherence of patients with systemic lupus erythematosus and rheumatoid arthritis considering the psychosocial factors, health literacy and current life concerns of patients","volume":"17","author":"Shenavandeh","year":"2021","journal-title":"Curr Rheumatol Rev"},{"key":"2025092900201204000_15.9.e096989.50","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/acr.23718","article-title":"The impact of belimumab and rituximab on health-related quality of life in patients with systemic lupus erythematosus","volume":"71","author":"Parodis","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025092900201204000_15.9.e096989.51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202443"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-096989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:20:30Z","timestamp":1759130430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-096989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,28]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2024-096989"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-096989","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}